Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological treatment of Parkinson's disease.

× No keyword cloud information.

103 in total

1. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.

Authors: Y Ben-Shlomo; A Churchyard; J Head; B Hurwitz; P Overstall; J Ockelford; A J Lees
Journal: BMJ Date: 1998-04-18

Review 2. Levodopa: is toxicity a myth?

Authors: Y Agid
Journal: Neurology Date: 1998-04 Impact factor: 9.910

Review 3. COMT inhibition: a new treatment strategy for Parkinson's disease.

Authors: M C Kurth; C H Adler
Journal: Neurology Date: 1998-05 Impact factor: 9.910

4. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease.

Authors: U K Rinne
Journal: Neurology Date: 1989-03 Impact factor: 9.910

5. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.

Authors: O Rascol; D J Brooks; E R Brunt; A D Korczyn; W H Poewe; F Stocchi
Journal: Mov Disord Date: 1998-01 Impact factor: 10.338

6. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.

Authors: A D Korczyn; D J Brooks; E R Brunt; W H Poewe; O Rascol; F Stocchi
Journal: Mov Disord Date: 1998-01 Impact factor: 10.338

7. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.

Authors: I Soykan; I Sarosiek; J Shifflett; G F Wooten; R W McCallum
Journal: Mov Disord Date: 1997-11 Impact factor: 10.338

Review 8. Progressive supranuclear palsy and corticobasal degeneration.

Authors: I Litvan
Journal: Baillieres Clin Neurol Date: 1997-04

9. Clozapine in the treatment of psychosis in Parkinson's disease.

Authors: J H Friedman; M C Lannon
Journal: Neurology Date: 1989-09 Impact factor: 9.910

10. Young onset Parkinson's disease.

Authors: N Quinn; P Critchley; C D Marsden
Journal: Mov Disord Date: 1987 Impact factor: 10.338

6 in total

Review 1. Parkinson's disease and primate research: past, present, and future.

Authors: E A C Pereira; T Z Aziz
Journal: Postgrad Med J Date: 2006-05 Impact factor: 2.401

2. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.

Authors: Brenda L Fredericksen; Bangdong L Wei; Jian Yao; Tianci Luo; J Victor Garcia
Journal: J Virol Date: 2002-11 Impact factor: 5.103

3. Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: randomised controlled trial.

Authors: Brian Jarman; Brian Hurwitz; Adrian Cook; Madhavi Bajekal; Alison Lee
Journal: BMJ Date: 2002-05-04

Review 4. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations.

Authors: Deborah A Burton; Grainne Nicholson; George M Hall
Journal: Drugs Aging Date: 2004 Impact factor: 3.923

5. Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity.

Authors: A Katherine Hatstat; Baiyi Quan; Morgan A Bailey; Michael C Fitzgerald; Michaela C Reinhart; Dewey G McCafferty
Journal: RSC Chem Biol Date: 2021-11-09

Review 6. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors: Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal: Int J Mol Sci Date: 2009-06-03 Impact factor: 6.208

6 in total